| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.491 | 26.241 | 26.603 | 33.803 | 38.363 | 41.696 | 44.426 | 51.894 | 70.087 | 79.401 |
| Total Income - EUR | 25.493 | 26.243 | 26.604 | 34.489 | 38.365 | 44.800 | 44.429 | 51.896 | 70.089 | 79.405 |
| Total Expenses - EUR | 13.299 | 13.510 | 15.658 | 16.509 | 17.545 | 23.918 | 25.755 | 26.403 | 28.751 | 34.780 |
| Gross Profit/Loss - EUR | 12.194 | 12.733 | 10.946 | 17.980 | 20.820 | 20.882 | 18.673 | 25.493 | 41.338 | 44.626 |
| Net Profit/Loss - EUR | 11.429 | 12.208 | 10.680 | 17.636 | 20.436 | 20.488 | 18.274 | 24.984 | 40.651 | 42.291 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Tisan Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 134 | 133 | 131 | 128 | 126 | 16.785 | 12.859 | 11.750 | 7.881 | 4.026 |
| Current Assets | 15.924 | 18.706 | 17.336 | 23.963 | 26.613 | 22.528 | 20.067 | 23.423 | 39.816 | 46.687 |
| Inventories | 0 | 935 | 920 | 903 | 885 | 868 | 849 | 852 | 849 | 0 |
| Receivables | 595 | 201 | 418 | 1.666 | 1.013 | 1.009 | 1.254 | 13.478 | 8.130 | 25.327 |
| Cash | 15.329 | 17.570 | 15.998 | 21.394 | 24.714 | 20.650 | 17.963 | 9.093 | 30.836 | 21.360 |
| Shareholders Funds | 13.884 | 16.916 | 15.327 | 22.276 | 24.978 | 24.972 | 23.541 | 29.388 | 45.026 | 44.439 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.175 | 1.924 | 2.140 | 1.815 | 1.760 | 14.341 | 9.385 | 5.785 | 2.671 | 6.274 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Tisan Med Srl